Non-Current Assets

Net Investment in Lease

Revolution Medicines, Inc. Net Investment in Lease decreased by 1.7% to $129.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.2%, from $115.78M to $129.90M. Over 5 years (FY 2020 to FY 2025), Net Investment in Lease shows an upward trend with a 36.9% CAGR.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2021
Last reportedQ1 2026

How to read this metric

An increase indicates growth in the bank's leasing business, while a decrease suggests a contraction in this lending segment.

Detailed definition

This represents the present value of future lease payments receivable from lessees, plus the unguaranteed residual value...

Peer comparison

Common among diversified regional banks with strong commercial and industrial lending divisions.

Metric ID: net_investment_in_lease

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$25.93M$25.23M$59.69M$58.57M$57.43M$56.26M$55.08M$54.30M$53.73M$53.12M$77.15M$76.19M$75.31M$74.34M$117.53M$115.78M$114.00M$134.45M$132.08M$129.90M
QoQ Change-2.7%+136.6%-1.9%-1.9%-2.0%-2.1%-1.4%-1.0%-1.1%+45.2%-1.2%-1.2%-1.3%+58.1%-1.5%-1.5%+17.9%-1.8%-1.7%
YoY Change+121.5%+122.9%-7.7%-7.3%-6.4%-5.6%+40.1%+40.3%+40.1%+39.9%+52.3%+52.0%+51.4%+80.9%+12.4%+12.2%
Range$25.23M$134.45M
CAGR+40.4%
Avg YoY Growth+39.9%
Median YoY Growth+40.1%
Current Streak2 quarters decline

Geographic Breakdown

View all
SegmentQ4 '21Q1 '23Q4 '24Q3 '25
Redwood City California$26.80M$25.00M$26.30M$22.40M
Total$59.69M$54.30M$117.53M$134.45M

Redwood City California was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.

Frequently Asked Questions

What is Revolution Medicines, Inc.'s net investment in lease?
Revolution Medicines, Inc. (RVMD) reported net investment in lease of $129.90M in Q1 2026.
How has Revolution Medicines, Inc.'s net investment in lease changed year-over-year?
Revolution Medicines, Inc.'s net investment in lease increased by 12.2% year-over-year, from $115.78M to $129.90M.
What is the long-term trend for Revolution Medicines, Inc.'s net investment in lease?
Over 5 years (2020 to 2025), Revolution Medicines, Inc.'s net investment in lease has grown at a 36.9% compound annual growth rate (CAGR), from $27.44M to $132.08M.
What does net investment in lease mean?
The total amount owed to the bank by customers under lease agreements, adjusted for present value.